Product
CMAB015
1 clinical trial
1 indication
Indication
PsoriasisClinical trial
Comparative Study of the Efficacy, Safety, and Immunogenicity of CMAB015 and Secukinumab in Adult Patients With Moderate-severe Chronic Plaque PsoriasisStatus: Not yet recruiting, Estimated PCD: 2025-05-31